Cardiac assessent in patients undergoing liver transplantation: M | 50564
Clinical & Experimental Cardiology

Clinical & Experimental Cardiology
Open Access

ISSN: 2155-9880

+44 1300 500008

Cardiac assessent in patients undergoing liver transplantation: Meta-analysis

3rd International Conference on Clinical & Experimental Cardiology

April 15-17, 2013 Hilton Chicago/Northbrook, USA

Daniel C Garcia, Francisco YB Macedo and Alexandre Benjo

AcceptedAbstracts: J Clin Exp Cardiolog

Abstract :

Introduction: Orthotopic liver transplantation (OLT) is the second most common transplant. Coronary artery disease (CAD) prevalence in patients with end-stage liver disease is equal or greater than the normal population. CAD leads to increase morbidity and mortality post-OLT.Routine evaluation evolves clinical risk factors, and EKG, dobutamine echocardiography stress test (DSE), SPECT, CT angiography (CTCAG) andcardiac catheterization indicated for positive test. Current ACC/AHA 2012 guidelines are unspecific andoutlines clinical evaluation, risk stratification and investigative tests as class III indication. Therefore, we aimed to review those actual available diagnostic tests and its predictive value for CAD in patients undergoing OLT. Methods: We systematically searched PubMed, EMBASE, and Cochrane up to January 2013. The outcomes studied were predictive value, sensitivity and specificity for CAD detection as well as mortality by using clinical risk factors and noninvasive test assess patients undergoing OLT. Results: Hypertension, advanced age, hyperlipidemia, diabetes (DM), obesity, typical anginal symptoms, history of CAD, stroke and CHF are the risk factors most associated to CAD. DM has been suggested to be the most predictive risk factor in patients over 50 years old to increase approximately twice the chance for cardiovascular event. Abnormal DSEin the presence of wall motion abnormalities only, is associated with a specificity and negative predictive value (NPV)close to 100%. DSE is a good predictor of cardiac events for patients with CAD or high risk but not for those with low to moderate risk of cardiac disease. SPECTpresents sensitivity and NPV close to 100%, butspecificity of15-61.Reversible defect are associated with higher incidence of cardiac and infection complications and withinferior but not significant survival in comparison with patients with normal or fixed defect. CTCAG is an alternative to patients illegibleto DES or SPECT and presents with better sensitivity by detecting extra11% of those patients with other negative test. For the last, EKG with QT interval greater or equal to 990 msecis a strong predictor ofintra- operative and post-OLT cardiac. Conclusion: Actual methods to assess CAD are good predictors of patients free of disease, and positive results might require further investigation to evaluate real disease and predict mortality.Nevertheless clinical trials comparing all those tests at the same time would elucidate the best predictive value, sensitivity and specificity.